CDH1 and ameloblastoma: In this study, we used immunohistochemistry to investigate the MMP‐7, ‐8, ‐9, beta‐catenin, and E‐cadherin immunoexpression in primary and recurrent ameloblastoma tissue samples from 34 patients.